Amid Rising Covid Fears, Wait For Patent Waiver On Meds Continues

December 26, 2022 |
Amid criticism over unaffordable insulin, Lilly strikes a manufacturing deal to supply Africa
The pandemic exposed global gaps in access to medicines. Can a contentious approach to close them gain traction?
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...